Catalyst Pharmaceuticals (CPRX) Interest Coverage Ratio Growth (1y) (2013 - 2026)
Catalyst Pharmaceuticals (CPRX) Interest Coverage Ratio Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.59% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -76.72% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 85.51% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 12.13% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 90.10% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -48.36% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1,170.12% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 99.48% |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | -7.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.53% |
| Dec 31, 2025 | -31.48% |
| Sep 30, 2025 | 74.42% |
| Jun 30, 2025 | 63.77% |
| Mar 31, 2025 | 213.03% |
| Dec 31, 2024 | -11.81% |
| Sep 30, 2024 | 703.18% |
| Jun 30, 2024 | 411.82% |
| Mar 31, 2024 | 235.65% |
| Dec 31, 2023 | 1,005.68% |
| Sep 30, 2023 | -103.78% |
| Jun 30, 2023 | -76.11% |
| Mar 31, 2023 | -96.76% |
| Dec 31, 2022 | -152.55% |
| Sep 30, 2022 | 114.44% |
| Jun 30, 2022 | -80.48% |
| Mar 31, 2022 | 1,644.47% |
| Dec 31, 2021 | 60.02% |
| Sep 30, 2021 | -86.67% |
| Mar 31, 2021 | -83.80% |